IBDEI23M ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,35595,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35595,1,3,0)
 ;;=3^Kidney and Ureter Disorders in Diseases Classd Elsewhr
 ;;^UTILITY(U,$J,358.3,35595,1,4,0)
 ;;=4^N29.
 ;;^UTILITY(U,$J,358.3,35595,2)
 ;;=^5015631
 ;;^UTILITY(U,$J,358.3,35596,0)
 ;;=N15.8^^134^1726^25
 ;;^UTILITY(U,$J,358.3,35596,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35596,1,3,0)
 ;;=3^Renal Tubulo-Interstitial Diseases
 ;;^UTILITY(U,$J,358.3,35596,1,4,0)
 ;;=4^N15.8
 ;;^UTILITY(U,$J,358.3,35596,2)
 ;;=^5015595
 ;;^UTILITY(U,$J,358.3,35597,0)
 ;;=N14.4^^134^1726^26
 ;;^UTILITY(U,$J,358.3,35597,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35597,1,3,0)
 ;;=3^Toxic Nephropathy NEC
 ;;^UTILITY(U,$J,358.3,35597,1,4,0)
 ;;=4^N14.4
 ;;^UTILITY(U,$J,358.3,35597,2)
 ;;=^5015594
 ;;^UTILITY(U,$J,358.3,35598,0)
 ;;=N05.6^^134^1726^18
 ;;^UTILITY(U,$J,358.3,35598,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35598,1,3,0)
 ;;=3^Nephritic Syndrome w/ Dense Deposit Disease,Unspec
 ;;^UTILITY(U,$J,358.3,35598,1,4,0)
 ;;=4^N05.6
 ;;^UTILITY(U,$J,358.3,35598,2)
 ;;=^5015547
 ;;^UTILITY(U,$J,358.3,35599,0)
 ;;=N05.7^^134^1726^19
 ;;^UTILITY(U,$J,358.3,35599,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35599,1,3,0)
 ;;=3^Nephritic Syndrome w/ Diffuse Crescentic Glomerulonephritis,Unspec
 ;;^UTILITY(U,$J,358.3,35599,1,4,0)
 ;;=4^N05.7
 ;;^UTILITY(U,$J,358.3,35599,2)
 ;;=^5015548
 ;;^UTILITY(U,$J,358.3,35600,0)
 ;;=N05.1^^134^1726^20
 ;;^UTILITY(U,$J,358.3,35600,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35600,1,3,0)
 ;;=3^Nephritic Syndrome w/ Focal/Segmental Glomerular Lesions,Unspec
 ;;^UTILITY(U,$J,358.3,35600,1,4,0)
 ;;=4^N05.1
 ;;^UTILITY(U,$J,358.3,35600,2)
 ;;=^5015542
 ;;^UTILITY(U,$J,358.3,35601,0)
 ;;=N05.0^^134^1726^21
 ;;^UTILITY(U,$J,358.3,35601,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35601,1,3,0)
 ;;=3^Nephritic Syndrome w/ Minor Glomerular Abnormality,Unspec
 ;;^UTILITY(U,$J,358.3,35601,1,4,0)
 ;;=4^N05.0
 ;;^UTILITY(U,$J,358.3,35601,2)
 ;;=^5015541
 ;;^UTILITY(U,$J,358.3,35602,0)
 ;;=N05.8^^134^1726^22
 ;;^UTILITY(U,$J,358.3,35602,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35602,1,3,0)
 ;;=3^Nephritic Syndrome w/ Morphologic Changes,Unspec
 ;;^UTILITY(U,$J,358.3,35602,1,4,0)
 ;;=4^N05.8
 ;;^UTILITY(U,$J,358.3,35602,2)
 ;;=^5134085
 ;;^UTILITY(U,$J,358.3,35603,0)
 ;;=R59.9^^134^1727^4
 ;;^UTILITY(U,$J,358.3,35603,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35603,1,3,0)
 ;;=3^Enlarged Lymph Nodes,Unspec
 ;;^UTILITY(U,$J,358.3,35603,1,4,0)
 ;;=4^R59.9
 ;;^UTILITY(U,$J,358.3,35603,2)
 ;;=^5019531
 ;;^UTILITY(U,$J,358.3,35604,0)
 ;;=R59.1^^134^1727^2
 ;;^UTILITY(U,$J,358.3,35604,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35604,1,3,0)
 ;;=3^Enlarged Lymph Nodes,Generalized
 ;;^UTILITY(U,$J,358.3,35604,1,4,0)
 ;;=4^R59.1
 ;;^UTILITY(U,$J,358.3,35604,2)
 ;;=^5019530
 ;;^UTILITY(U,$J,358.3,35605,0)
 ;;=R59.0^^134^1727^3
 ;;^UTILITY(U,$J,358.3,35605,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35605,1,3,0)
 ;;=3^Enlarged Lymph Nodes,Localized
 ;;^UTILITY(U,$J,358.3,35605,1,4,0)
 ;;=4^R59.0
 ;;^UTILITY(U,$J,358.3,35605,2)
 ;;=^5019529
 ;;^UTILITY(U,$J,358.3,35606,0)
 ;;=D64.9^^134^1727^1
 ;;^UTILITY(U,$J,358.3,35606,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35606,1,3,0)
 ;;=3^Anemia,Unspec
 ;;^UTILITY(U,$J,358.3,35606,1,4,0)
 ;;=4^D64.9
 ;;^UTILITY(U,$J,358.3,35606,2)
 ;;=^5002351
 ;;^UTILITY(U,$J,358.3,35607,0)
 ;;=R79.9^^134^1728^1
 ;;^UTILITY(U,$J,358.3,35607,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35607,1,3,0)
 ;;=3^Abnormal Finding of Blood Chemistry,Unspec
 ;;^UTILITY(U,$J,358.3,35607,1,4,0)
 ;;=4^R79.9
